293 related articles for article (PubMed ID: 10763819)
1. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
Lai HK; Borden KL
Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
[TBL] [Abstract][Full Text] [Related]
2. Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner.
Topisirovic I; Capili AD; Borden KL
Mol Cell Biol; 2002 Sep; 22(17):6183-98. PubMed ID: 12167712
[TBL] [Abstract][Full Text] [Related]
3. PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA.
Cohen N; Sharma M; Kentsis A; Perez JM; Strudwick S; Borden KL
EMBO J; 2001 Aug; 20(16):4547-59. PubMed ID: 11500381
[TBL] [Abstract][Full Text] [Related]
4. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E.
Rousseau D; Kaspar R; Rosenwald I; Gehrke L; Sonenberg N
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1065-70. PubMed ID: 8577715
[TBL] [Abstract][Full Text] [Related]
5. Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels.
Rosenwald IB; Kaspar R; Rousseau D; Gehrke L; Leboulch P; Chen JJ; Schmidt EV; Sonenberg N; London IM
J Biol Chem; 1995 Sep; 270(36):21176-80. PubMed ID: 7673150
[TBL] [Abstract][Full Text] [Related]
6. The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E.
Kentsis A; Dwyer EC; Perez JM; Sharma M; Chen A; Pan ZQ; Borden KL
J Mol Biol; 2001 Sep; 312(4):609-23. PubMed ID: 11575918
[TBL] [Abstract][Full Text] [Related]
7. The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner.
Campbell Dwyer EJ; Lai H; MacDonald RC; Salvato MS; Borden KL
J Virol; 2000 Apr; 74(7):3293-300. PubMed ID: 10708446
[TBL] [Abstract][Full Text] [Related]
8. The promyelocytic leukemia protein stimulates SUMO conjugation in yeast.
Quimby BB; Yong-Gonzalez V; Anan T; Strunnikov AV; Dasso M
Oncogene; 2006 May; 25(21):2999-3005. PubMed ID: 16501610
[TBL] [Abstract][Full Text] [Related]
9. eIF4E is a central node of an RNA regulon that governs cellular proliferation.
Culjkovic B; Topisirovic I; Skrabanek L; Ruiz-Gutierrez M; Borden KL
J Cell Biol; 2006 Nov; 175(3):415-26. PubMed ID: 17074885
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E.
Rosenwald IB; Lazaris-Karatzas A; Sonenberg N; Schmidt EV
Mol Cell Biol; 1993 Dec; 13(12):7358-63. PubMed ID: 8246956
[TBL] [Abstract][Full Text] [Related]
11. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
Duprez E; Lillehaug JR; Naoe T; Lanotte M
Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
[TBL] [Abstract][Full Text] [Related]
12. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.
Boddy MN; Howe K; Etkin LD; Solomon E; Freemont PS
Oncogene; 1996 Sep; 13(5):971-82. PubMed ID: 8806687
[TBL] [Abstract][Full Text] [Related]
13. PML bodies: a meeting place for genomic loci?
Ching RW; Dellaire G; Eskiw CH; Bazett-Jones DP
J Cell Sci; 2005 Mar; 118(Pt 5):847-54. PubMed ID: 15731002
[TBL] [Abstract][Full Text] [Related]
14. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
[TBL] [Abstract][Full Text] [Related]
15. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
16. The biologic function of PML and its role in acute promyelocytic leukemia.
Mu ZM; Le XF; Glassman AB; Chang KS
Leuk Lymphoma; 1996 Oct; 23(3-4):277-85. PubMed ID: 9031108
[TBL] [Abstract][Full Text] [Related]
17. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.
Rivera OJ; Song CS; Centonze VE; Lechleiter JD; Chatterjee B; Roy AK
Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612
[TBL] [Abstract][Full Text] [Related]
18. [Research advances on function of promyelocytic leukemia (PML) protein].
He PC; Zhang M; Wang F
Ai Zheng; 2003 Dec; 22(12):1359-62. PubMed ID: 14693070
[TBL] [Abstract][Full Text] [Related]
19. Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies.
Borden KL
Mol Cell Biol; 2002 Aug; 22(15):5259-69. PubMed ID: 12101223
[No Abstract] [Full Text] [Related]
20. Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival.
Fagioli M; Alcalay M; Tomassoni L; Ferrucci PF; Mencarelli A; Riganelli D; Grignani F; Pozzan T; Nicoletti I; Grignani F; Pelicci PG
Oncogene; 1998 Jun; 16(22):2905-13. PubMed ID: 9671411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
